The opportunity

Synthetic biology is a multidisciplinary field that uses engineering techniques to modify and improve biological components like living cells. Europe excels in synthetic biology research, however, more funding and support on entrepreneurship are needed to boost opportunities for commercialisation. We’re here to fill the gap.

Our vision

We see a world where synthetic biology plays a transformative role in solving some of the world’s most pressing challenges. We believe that synthetic biology has the potential to revolutionize industries, create new markets, and provide solutions to complex problems that were previously thought to be unsolvable.

Our mission

Our investment company is committed to supporting the development and growth of synthetic biology companies in Europe, the UK, and Israel. Our mission is to identify and invest in companies that are developing cutting-edge synthetic biology technologies, with a focus on those that have the potential to transform industries such as healthcare, agriculture, energy, and environmental sustainability. Our portfolio of investments reflects our commitment to advancing the field of synthetic biology and creating a more sustainable and equitable world.

Meet the team

Backed by a Board of renowned scientific experts, our leadership team and staff have exceptional experience in science and business.

Meet the team

Backed by a Board of renowned scientific experts, our leadership team and staff have exceptional experience in science and business.

Alexandre Mouradian

Founder, Chairman and CEO
Alexandre Mouradian is Chairman of the Mouradian Foundation, a charitable organization set up to promote a deeper understanding of the global society challenges, and which has forged partnerships with leading academic centers in the world. He has advised multiple hedge funds since 1993 and he is one of the few who correctly forecast the 2008 Financial Crisis. He is a graduate of the √Čcole sup√©rieur de Commerce de Paris (ESCP).
Linkedin

Kristin Thompson

VP, Chief Operating Officer
Kristin Thompson is former head of strategic partnerships in microbiome at Bioaster. Before that, Dr. Thompson was senior BD manager at Famar and BD manager of the French biotech company DaVolterra. She worked in research at French INSERM and the University of North Carolina, Chapel Hill. She holds a PhD in molecular biology from the University of Ulm, Germany.
Linkedin

Board of Directors

These top leaders guide the decisions we make.

Alexandre Mouradian

Founder, Chairman and CEO
Alexandre Mouradian is Chairman of the Mouradian Foundation, a charitable organization set up to promote a deeper understanding of the global society challenges, and which has forged partnerships with leading academic centers in the world. He has advised multiple hedge funds since 1993 and he is one of the few who correctly forecast the 2008 Financial Crisis. He is a graduate of the √Čcole sup√©rieur de Commerce de Paris (ESCP).
Linkedin

Anne Lauvergeon

Member
Anne has held various positions in French Government and the energy industry ‚Äď most notable as CEO of Areva. She currently acts as an advisor to many energy companies. Her training is in engineering and physics from the √Čcole normale sup√©rieure and the √Čcole nationale sup√©rieure des mines de Paris.
Linkedin

Gerard Le Fur

Member
Gerard has more than 30 years experience in the pharmaceutical industry working in both research and development and general management. Most notably, he is a former CEO of Sanofi. He holds a doctorate in pharmacology and is a member of France’s Académie de sciences.
Linkedin

Scientific Advisory Board

Dr. George Weinstock

Member
Dr. George Weinstock is an American geneticist and microbiologist, Professor at Evnin Family and Director of Microbial Genomics at the Jackson Laboratory for Genomic Medicine.. He has worked in genomics and microbiology for over 40 years. Previously, he was the co-director of the Human Genome Sequencing Center at Baylor College of Medicine in Houston where he was one of the leaders of the Human Genome Project.
LinkedIn

Dr. Joel Dore

Member
Research Director at INRA, Pr. Dore is Scientific Director of MetaGenoPolis, a Unit of the Micalis Institute ‚ÄúFood and Gut Microbiology for Human Health‚ÄĚ. He aims to contribute to a better understanding of the intestinal ecosystem in order to support therapeutic choices. He received his PhD from the University of Illinois at Urbana-Champaign.
Linkedin

Prof. Dr. Sven Panke

Member
Prof. Dr. Panke is part of the Department of Biosystems Science and Engineering at ETH Zurich. He is a leading scientist at the forefront of synthetic biology in Europe. He published landmark papers in the field of synthetic biology, systems biology, and process engineering. His work was awarded with the ETH Medal and the DSM Research Award.
About

Dr. Leroy Hood

Member
A pillar in the biotechnology field, Dr. Hood has played a role in founding fifteen companies, including Amgen and Applied Biosystems. He is one of the fathers of gene sequencing. He is a member of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. Dr. Hood graduated from Caltech with a PhD in biochemistry.
Linkedin

Dr. Antoine Danchin

Chairman
Prof. Danchin is a French geneticist known for his research in several fields of biology, from the structure and function of adenylate cyclase, to modelization of learning in the nervous system and the early development of genomics and bioinformatics. He was the director of the Department Genomes and Genetics at the Institute Pasteur in Paris.
Linkedin

Dr. Pamela Silver

Member
Pr. Silver is an American cell and systems biologist and a bioengineer. She is one of the founding members of the Department of Systems Biology at Harvard Medical School, where she runs the Silver Lab. She has been named one of the top twenty Global Synthetic Biology Influencers and has served on numerous government advisory panels.
About

Dr. Felix Rey

Member
Dr. Rey is a structural biologist who spent 7-years as post-doctoral fellow at Harvard University, where he specialized in the structure of viruses. He created the Structural Virology Unit at Institute Pasteur. His research focus has included the 3D structures of viral polymerases and the study of viral envelope proteins.
LinkedIn

Reach out to our team

Luxembourg | France | Belgium

Subscribe to our news to keep in touch

Luxembourg | France | Belgium